{name}
{subtitle}
Efficacy, Safety, and Tolerability of V937 Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)
city
~72 mi. (La Tronche, France, +25 more cities)
facility
CHU de Grenoble Hopital Nord ( Site 2027)
drug
coxsackievirus A21, +1 more drug
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
city
~87 mi. (Valence, France, +137 more cities)
facility
Centre Hospitalier de Valence-Service de Dermatologie ( Site 0377)
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~95 mi. (Avignon, France, +226 more cities)
facility
Institut Sainte Catherine ( Site 0447)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
city
~95 mi. (Avignon, France, +207 more cities)
facility
Institut Sainte Catherine ( Site 0916)
biomarker
ER Positive, +1 more biomarker
drug
cyclophosphamide, +6 more drugs
drug type
chemotherapy, +3 more types
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
city
~95 mi. (Avignon, France, +159 more cities)
facility
Institut Sainte Catherine ( Site 0454)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +1 more type
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
city
~95 mi. (Avignon, France, +150 more cities)
facility
Institut Sainte Catherine ( Site 0352)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +2 more types
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)
city
~95 mi. (Avignon, France, +92 more cities)
facility
Institut Sainte Catherine ( Site 0121)
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types